U.S. Physical Therapy, Inc.
USPH
$80.84
-$2.14-2.58%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 8.90% | 7.64% | 7.53% | 7.75% | 10.75% |
Total Other Revenue | 22.77% | 17.99% | 10.87% | 5.21% | 1.91% |
Total Revenue | 10.99% | 9.20% | 8.04% | 7.35% | 9.32% |
Cost of Revenue | 12.30% | 6.94% | 6.16% | 5.30% | 6.09% |
Gross Profit | 6.55% | 18.06% | 15.32% | 15.27% | 21.86% |
SG&A Expenses | 12.20% | 13.29% | 8.96% | 7.78% | 12.67% |
Depreciation & Amortization | 19.34% | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 12.49% | 10.45% | 9.39% | 8.55% | 9.83% |
Operating Income | -0.42% | -0.20% | -2.05% | -1.42% | 5.59% |
Income Before Tax | 21.94% | -21.99% | -15.99% | -8.72% | -11.15% |
Income Tax Expenses | 20.18% | -14.95% | -3.86% | 5.94% | -0.07% |
Earnings from Continuing Operations | 22.51% | -24.00% | -19.32% | -12.70% | -14.25% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -57.84% | 23.08% | 26.50% | 29.36% | 20.16% |
Net Income | 11.28% | -24.36% | -16.50% | -6.16% | -12.19% |
EBIT | -0.42% | -0.20% | -2.05% | -1.42% | 5.59% |
EBITDA | 3.16% | 1.89% | 0.28% | 0.40% | 5.75% |
EPS Basic | 37.38% | -45.36% | -45.27% | -43.16% | -40.64% |
Normalized Basic EPS | -22.09% | 17.34% | 15.52% | 15.26% | 11.34% |
EPS Diluted | 37.38% | -45.25% | -45.17% | -43.07% | -40.51% |
Normalized Diluted EPS | -22.09% | 17.34% | 15.52% | 15.26% | 11.34% |
Average Basic Shares Outstanding | 6.23% | 9.90% | 13.87% | 12.85% | 9.21% |
Average Diluted Shares Outstanding | 6.23% | 9.90% | 13.87% | 12.85% | 9.21% |
Dividend Per Share | 2.33% | 2.94% | 3.57% | 4.22% | 4.88% |
Payout Ratio | -0.01% | 0.51% | 0.43% | 0.21% | 0.29% |